Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
EDMONTON, Alberta, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the “Company”) has released its financial results for the second quarter ended June 30, 2013.
Recent Developments
On February 5, 2013 the Company announced that it had signed a binding term sheet (the “Term Sheet”) with privately held Aurinia Pharmaceuticals Inc. (“Aurinia”) for the merger of the two companies, creating a clinical development stage pharmaceutical company focused on the global nephrology market.
Help employers find you! Check out all the jobs and post your resume.
